|[April 17, 2014]
Agilent Technologies Thought Leader Award Supports Dr. Joshua Rabinowitz's Research at Princeton University
SANTA CLARA, Calif. --(Business Wire)--
Agilent Technologies (News - Alert) Inc. (NYSE: A) today announced that Joshua
Rabinowitz, M.D., Ph.D., professor at Princeton University's
Department of Chemistry and the Lewis-Sigler
Institute for Integrative Genomics, has received an Agilent Thought
Leader Award to support his work on quantitative analysis of cellular
Dr. Rabinowitz is a world-renowned scientist who has made seminal
conceptual and methodological contributions to the metabolomics field.
These include the development of isotopic labeling, sample preparation,
data analysis, and information visualization techniques for liquid
chromatography/mass spectrometry data. Together these techniques allow
researchers to piece together static snapshots of metabolite levels
provided by LC/MS into an understanding of dynamic metabolic activity in
living systems. Dr. Rabinowitz has applied these tools to identify
metabolic remodeling in infectious disease and cancer pathogenesis. The
resulting understanding has led to new targets for therapeutic
"We are very happy to expand our work with Dr. Rabinowitz and his team
to support their efforts developing quantitative proteomics
methodologies and pan-omics studies of metabolism," said John Fjeldsted,
Agilent's director of Mass Spectrometry Research and Development. "We
believe this workwill have a significant impact in many fundamental
areas of research."
The Agilent award will support Dr. Rabinowitz's research on global cell
metabolism and its regulation. He will make use of the quantitative
capabilities of the Agilent 6550 MS-QTOF to generate protein stability
information to supplement transcriptomics, proteomics, metabolomics, and
metabolic flux data sets. From protein abundances and stabilities, he
will be able to infer protein fluxes and thereby assemble an integrative
understanding of how protein levels are regulated and how this ties into
overall cellular metabolic activity.
"I am delighted to be working with Agilent, whose combined expertise in
wet chemistry, instrumentation and software makes them an outstanding
partner for my lab," said Dr. Rabinowitz. "We share Agilent's goal of
enabling quantitative measurement of all key biomolecules, and of
building computational tools that integrate such data to reveal new
principles of living systems. Such tools hold the potential to
revolutionize biomedical research."
The Agilent Thought Leader Award promotes fundamental scientific
advances by contributing financial support, products and expertise to
the research of influential thought leaders in life sciences and
chemical analysis. Information about previous award recipients is
available at Agilent's Thought
Leader Program website.
The Lewis-Sigler Institute for Integrative Genomics
The Lewis-Sigler Institute for Integrative Genomics, housed in the Carl
Icahn Laboratory at Princeton University, was established to innovate in
research and teaching at the interface of modern biology and the more
quantitative sciences. The Institute is the hub of the Center
for Quantitative Biology, funded by the National Institute of
General Medical Sciences, one branch of the National Institutes of
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement
company and a technology leader in chemical analysis, life sciences,
diagnostics, electronics and communications. The company's 20,600
employees serve customers in more than 100 countries. Agilent had
revenues of $6.8 billion in fiscal 2013. Information about Agilent is
available at www.agilent.com.
On Sept. 19, 2013, Agilent announced plans to separate into two publicly
traded companies through a tax-free spinoff of its electronic
measurement business. The new company is named Keysight Technologies,
Inc. The separation is expected to be completed in early November 2014.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available at www.agilent.com/go/news.
[ Back To TMCnet.com's Homepage ]